Related content

Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

By  

Pharmacology, Vol. 85, Iss. 6, 2010-06 ,pp. : 350-356

Karger

Access to resources Recommend Favorite

Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein

By Tachibana T.   Kato M.   Watanabe T.   Mitsui T.   Sugiyama Y.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 430-443

Informa Healthcare

Access to resources Recommend Favorite

Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite

P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification

By Chan Lauretta M.S.   Cooper Anne E.   Dudley Adam L.J.   Ford Dianne   Hirst Barry H.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

Functional interactions between P-glycoprotein and CYP3A in drug metabolism

By Christians Uwe   Schmitz Volker   Haschke Manuel  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 641-654

Informa Healthcare

Access to resources Recommend Favorite